Moderately hard move to the downside - 3.4% Loss

Another quite hard blow with 3.4% loss overall. 

There were no double digit losses but fully 12 stocks dropped 5% or more.

Only Generex and Vir gained with the other 25 losing ground.

iBio continued its down hill slalom leading the way down the hill, losing 7%. PDS dropped just under 7%. 

CureVac seems to be headed to 0 with another 6% loss. Immunity Bio, IMV and Inovio all lost over 6%.